MedTrace Logo

A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients

NCT05795023 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-10-29

No results posted yet for this study

Summary

This is a prospective study in a cohort of about 30 patients with Idiopathic Parkinson's disease, who will be evaluated with a clinical assessment and an oculometric examination during a time period with specific intervals.

This study aims to evaluate the correlation between oculometric measures and clinical assessment over time.

Conditions

  • Parkinson Disease

Interventions

OTHER

NeuraLight

NeuraLight software-based platform

Sponsors & Collaborators

  • NeuraLight

    lead INDUSTRY

Principal Investigators

  • Tanya Gurevich, MD · Tel Aviv Medical Center

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-08
Primary Completion
2024-10-28
Completion
2024-10-28

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05795023 on ClinicalTrials.gov